To plan your abstract: Click here to preview the abstract form.
To submit your abstract: Click "Continue" below. (All abstracts must be submitted through the online form.)
The Excipient Imperative: Powering the Next Era of Quality, Safety, and Supply Resilience
As the pharmaceutical industry enters the next era of drug development and manufacturing, excipients remain critical to product quality, patient safety, and supply chain resilience. EW27 will explore the latest scientific, regulatory, and operational developments shaping the future of excipients and the medicines they enable. Attendees will gain practical insights, real-world examples, and actionable strategies to address today's challenges and position their organizations for success.
Presenting at EW is a great opportunity to demonstrate your thought leadership AND get visibility for your company. As an added bonus, approved presenters receive complimentary event registration -- including access to education sessions, exhibit hall, and networking functions!
The deadline for submitting abstracts is October 2, 2026. Abstracts can be submitted after this date by invitation only. Submissions will be reviewed by the Excipient World planning team and selected based on relevance, originality/timeliness, educational emphasis, and speaker qualifications.
We welcome practical case studies, lessons learned, and innovative perspectives on topics including:
> Excipient Impurity Control & Risk Mitigation > Novel Excipient Development, Safety & Approval > Regional Standards & Global Compliance > Supplier Qualification & Risk-Based Oversight > Compatibility, stability, and formulation challenges > Excipient composition and nomenclature
> Formulations > Supply Chain > Quality/Regulatory
Case studies (20 min) - How did an organization successfully address a specific excipient safety, quality, regulatory, or supply chain challenge? As a general guide, content should be structured as follows: > 10% Organizational context > 35% Business challenge > 40% Implementation journey > 15% Outcomes and lessons learned Educational Session (45 min) - What do excipient professionals need to know about the latest scientific, regulatory, and operational developments? As a general guide, content should be structured as follows: > 25% Industry context and trends > 35% Concepts, principles, or framework > 25% Best practices and examples > 15% Discussion and Q&A Technical deep dives (45 min) - How can organizations implement, validate, and sustain specific approaches to excipient quality, safety, compliance, or supply resilience? As a general guide, content should be structured as follows: > 15% Problem statement and requirements > 50% Architecture, methodology, process, or implementation details > 20% Validation, governance, risks, or troubleshooting > 15% Examples and Q&A Interactive workshops (90-180 min) - How can excipient professionals apply tools, frameworks, or best practices within their own organizations? As a general guide, content should be structured as follows: > 20% Context and framework > 15% Demonstration or examples > 50% Hands-on exercises, discussion, or activities > 15% Debrief, feedback, and action planning
Keynotes (60 min) - Where are excipients headed in the next era of safety, quality, and supply resilience? Panel discussions (60 min) - How are industry leaders approaching today's most pressing excipient challenges and opportunities?
Supplier innovation sessions (10 min) - What new technologies, services, materials, or capabilities are emerging to strengthen excipient quality, safety, and supply continuity? As a general guide, content should be structured as follows: > 40% Industry challenge > 30% Innovative approach > 20% Customer experience > 10% Product specifics Questions regarding the abstract submission process should be directed to Courtney Nazareno, 571-814-3450, Courtney@ExcipientWorld.org.
